lifestyle.mmminimal.com

Author: Neurolief

Neurolief to Showcase Proliv®Rx at APA 2026, Highlighting FDA-Approved, Physician-Directed At-Home Brain Stimulation for Major Depressive Disorder

May 12, 2026
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants

March 30, 2026
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants

January 12, 2026